Anti-P2Y12/ P2RY12/ ADPG-R monoclonal antibody

Anti-P2Y12/ P2RY12/ ADPG-R antibody for FACS & in-vivo assay

Target products collectionGo to P2RY12/P2RY12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T46937-Ab-1/ GM-Tg-hg-T46937-Ab-2Anti-Human P2RY12 monoclonal antibodyHuman
GM-Tg-rg-T46937-Ab-1/ GM-Tg-rg-T46937-Ab-2Anti-Rat P2RY12 monoclonal antibodyRat
GM-Tg-mg-T46937-Ab-1/ GM-Tg-mg-T46937-Ab-2Anti-Mouse P2RY12 monoclonal antibodyMouse
GM-Tg-cynog-T46937-Ab-1/ GM-Tg-cynog-T46937-Ab-2Anti-Cynomolgus/ Rhesus macaque P2RY12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T46937-Ab-1/ GM-Tg-felg-T46937-Ab-2Anti-Feline P2RY12 monoclonal antibodyFeline
GM-Tg-cang-T46937-Ab-1/ GM-Tg-cang-T46937-Ab-2Anti-Canine P2RY12 monoclonal antibodyCanine
GM-Tg-bovg-T46937-Ab-1/ GM-Tg-bovg-T46937-Ab-2Anti-Bovine P2RY12 monoclonal antibodyBovine
GM-Tg-equg-T46937-Ab-1/ GM-Tg-equg-T46937-Ab-2Anti-Equine P2RY12 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T46937-Ab-1/ GM-Tg-hg-T46937-Ab-2; GM-Tg-rg-T46937-Ab-1/ GM-Tg-rg-T46937-Ab-2;
GM-Tg-mg-T46937-Ab-1/ GM-Tg-mg-T46937-Ab-2; GM-Tg-cynog-T46937-Ab-1/ GM-Tg-cynog-T46937-Ab-2;
GM-Tg-felg-T46937-Ab-1/ GM-Tg-felg-T46937-Ab-2; GM-Tg-cang-T46937-Ab-1/ GM-Tg-cang-T46937-Ab-2;
GM-Tg-bovg-T46937-Ab-1/ GM-Tg-bovg-T46937-Ab-2; GM-Tg-equg-T46937-Ab-1/ GM-Tg-equg-T46937-Ab-2
Products NameAnti-P2RY12 monoclonal antibody
Formatmab
Target NameP2RY12
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-P2RY12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species P2Y12/ P2RY12/ ADPG-R VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP003557human P2RY12 Lentivirus particle
    ORF Viral VectorpGMLP003557human P2RY12 Lentivirus plasmid


    Target information

    Target IDGM-T46937
    Target NameP2RY12
    Gene ID64805,70839,64803,710036,442958,101094044,408007,100630046
    Gene Symbol and Synonyms2900079B22Rik,4921504D23Rik,ADPG-R,BDPLT8,HORK3,P2RY12,P2T(AC),P2Y(12)R,P2Y(AC),P2Y(ADP),P2Y(cyc),P2Y12,SP1999
    Uniprot AccessionQ9H244,Q9EPX4
    Uniprot Entry NameP2Y12_HUMAN,P2Y12_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000169313
    Target ClassificationGPCR

    The target: P2RY12, gene name: P2RY12, also named as ADPG-R, BDPLT8, HORK3, P2T(AC), P2Y(12)R, P2Y(AC), P2Y(ADP), P2Y(cyc), P2Y12, SP1999. The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.